Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature

T Minamoto, Z Ronai, M Mai, K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review. Cancer Detection and Prevention. ,vol. 24, pp. 1- 12 ,(2000)

M.Jane Arboleda, Derek Eberwein, Barbara Hibner, John F. Lyons, Dominant negative mutants of mitogen-activated protein kinase pathway. Methods in Enzymology. ,vol. 332, pp. 353- 367 ,(2001) , 10.1016/S0076-6879(01)32215-2

Marcia S Brose, Patricia Volpe, Michael Feldman, Madhu Kumar, Irum Rishi, Renee Gerrero, Eugene Einhorn, Meenhard Herlyn, John Minna, Andrew Nicholson, Jack A Roth, Steven M Albelda, Helen Davies, Charles Cox, Graham Brignell, Philip Stephens, P Andrew Futreal, Richard Wooster, Michael R Stratton, Barbara L Weber, None, BRAF and RAS mutations in human lung cancer and melanoma Cancer Research. ,vol. 62, pp. 6997- 7000 ,(2002)

Edna T Kimura, Marina N Nikiforova, Zhaowen Zhu, Jeffrey A Knauf, Yuri E Nikiforov, James A Fagin, None, High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Research. ,vol. 63, pp. 1454- 1457 ,(2003)

Maria Karasarides, Antonio Chiloeches, Robert Hayward, Dan Niculescu-Duvaz, Ian Scanlon, Frank Friedlos, Lesley Ogilvie, Douglas Hedley, Jan Martin, Christopher J Marshall, Caroline J Springer, Richard Marais, B-RAF is a therapeutic target in melanoma. Oncogene. ,vol. 23, pp. 6292- 6298 ,(2004) , 10.1038/SJ.ONC.1207785

Amir S. Yazdi, Gabriele Palmedo, Michael J. Flaig, Ursula Puchta, Andrea Reckwerth, Arno Rütten, Thomas Mentzel, Heino Hügel, Markus Hantschke, Monika-Hildegard Schmid-Wendtner, Heinz Kutzner, Christian A. Sander, Mutations of the BRAF gene in benign and malignant melanocytic lesions. Journal of Investigative Dermatology. ,vol. 121, pp. 1160- 1162 ,(2003) , 10.1046/J.1523-1747.2003.12559.X

Harith Rajagopalan, Alberto Bardelli, Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein, Victor E. Velculescu, Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. ,vol. 418, pp. 934- 934 ,(2002) , 10.1038/418934A

Gretchen A. Repasky, Emily J. Chenette, Channing J. Der, Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? Trends in Cell Biology. ,vol. 14, pp. 639- 647 ,(2004) , 10.1016/J.TCB.2004.09.014

Walter Kolch, Muffy Calder, David Gilbert, When kinases meet mathematics: the systems biology of MAPK signalling. FEBS Letters. ,vol. 579, pp. 1891- 1895 ,(2005) , 10.1016/J.FEBSLET.2005.02.002

Sebastien Hotte, Hal Hirte, BAY 43-9006: early clinical data in patients with advanced solid malignancies. Current Pharmaceutical Design. ,vol. 8, pp. 2249- 2253 ,(2002) , 10.2174/1381612023393053